In just a month or so, Mölndal-based Fluicell has taken on a new form. Strengthened by the collaboration with Breakthrough T1D, the license agreement with Ambusol and the order from The Francis Crick Institute, the company has sailed...
You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.